Clinical NGS Data Analysis Software - NGeneAnalySys
● Product Introduction - NGeneAnalySysTM
NGeneBio clinical NGS analysis SW platform.
It provides accurate pathogenic variants information based on ACMG guideline and relevant therapy information based on databases (solid tumor / hematologic malignancies), which enables efficient on-site data analysis for clinical NGS.
- Clinical SW for NGS diagnostics
- GMP/ISO13485 certified
- Korea MFDS IVD (KFDA class II) approved (Dec/2017);
- combined with BRCAaccuTest
- CE-IVD marked (Jun/2017)
- Integrated DBs for clinical significance & relevant drug information provided
● Features
Advanced analytical platform
- Compliance with ACMG guideline for NGS clinical use
- Provides tier-based reporting with therapeutic drug information and clinical trials
- Detected variants list with detailed information and visual charts
Accurate interpretation
: Recent databases employed and In Silico prediction
- Reference sequence DB
- Population DB
- Cancer specific DB
- Constitutional variant DB
- Internal DB
Create Report
- Provides QC report on sample data and clinical report of variants analysis
Easy analysis
- From data uploading to analysis result by one UI operation
Information
- NGeneAnalysys V.1.1 is compatible with NGeneBio BRCAaccuTest
- NGeneAnalysys V.1.3 is compatible with NGeneBio all clinical NGS kits (BRCAaccuTest/BRCAaccuTestPLUS/SOLIDaccuTest/HEMEaccuTest) and Illumina TruSight Tumor 170